Yesterday, we ran a post called In defense of The New York Times, which detailed a very public battle between The New York Times (exposé of Amazon) and Amazon (Medium post rebutting those charges).

In the post, Ben Thompson made the point that these types of battles are now being fought in public, that newspapers no longer control the means of mass communication.

A few days ago, we ran a post about Theranos, linking to Jean-Louis Gassée’s first person encounter with the blood-testing medical startup embroiled in its own battle with The Wall Street Journal.

In an eerie parallel with the Amazon/NYTimes back and forth, Theranos has posted its own public rebuttal to the negative media coverage.

As a consumer, the heart of this story is the accuracy of the Theranos blood tests. In their blog post, Theranos detailed the FDA approval of their process. If there is an issue, surely the FDA would respond in some way.

More as this unfolds but, point is, we’re seeing a new forum for the court of public opinion.